ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETF vs HDFC Pharma and Healthcare Fund

ABSL vs HDFC· Portfolio Overlap Analysis

47.8%High Overlap
10 common stocksRank #12461 / 20,000

Investor takeaway: At 47.8% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.

Common Holdings (10)

StockWt% in ADITYA BIRLA SUN LIFE NIFTY HEWt% in HDFC Pharma and HealthcareOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
18.36%9.81%9.81%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
8.13%8.38%8.13%
Max Healthcare Institute Limited
Healthcare Services
8.11%6.36%6.36%
Lupin Limited
Pharmaceuticals & Biotechnology
5.57%6.44%5.57%
Fortis Healthcare Limited
Healthcare Services
4.90%4.02%4.02%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
3.29%6.21%3.29%
Glenmark Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
3.21%6.62%3.21%
Laurus Labs Limited
Pharmaceuticals & Biotechnology
4.17%2.91%2.91%
Torrent Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
4.52%2.34%2.34%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
2.12%4.80%2.12%

Unique to ADITYA BIRLA SUN LIFE NIFTY HE

  • Apollo Hospitals Enterprise Limited8.04%
  • Dr. Reddys Laboratories Limited7.82%
  • Cipla Limited7.57%

Unique to HDFC Pharma and Healthcare

  • Aster DM Healthcare Limited5.42%
  • Anthem Biosciences Limited4.46%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
37.4% (8)
Healthcare Services
10.4% (2)

More comparisons for ADITYA BIRLA SUN LIFE NIFTY HE

More comparisons for HDFC Pharma and Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.